SGMO

#3969
Sangamo Therapeutics, Inc. Common Stock
0.26 USD
0.00%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.26
0.26
Range Annuel
0.21
0.84
Changement quotidien
0.00%
Changement Mensuel
-35.00%
Evolution sur 6 mois
-62.86%
Changement Annuel
-65.33%
Clôture Précédente
0.26
Open
0.26
Bid
Ask
Low
0.26
High
0.26
Volume
11
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

Nouvelles